Facebook
Twitter
LinkedIn
ForwardUpdates in Breast Cancer: Hypofractionation, Treatment Techniques, and Systemic Therapy (PRO 01)
This activity involves three discussants using case-based presentations to review recent advances in breast cancer treatment. The first discussant addresses hypofractionation and ultrahypofractionation techniques for breast radiation. The second discussant reviews different techniques in breast patient set-up and motion management. The third discussant reviews recent advances in systemic therapy for breast cancer patients.
Target Audience
The activity is designed to meet the interests of radiation oncologists and radiation therapists.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Discuss various techniques for breast cancer patient set-up and motion management.
- Discuss hypofractionation and ultra-hypofractionation techniques.
Christine S. Chung, MD, is employed by Alta Bates Comprehensive Cancer Center and John Muir Health.
Najeeb Mohideen, MD, FASTRO, is employed by Northwest Community Hospital. Dr. Mohideen serves as President of the Radiosurgery Society.
Nicolas Demetrios Prionas, MD, PhD, is employed by the University of California, San Francisco.
Jolinta Y. Lin, MD, is employed by Emory University School of Medicine.
Cathie Chung, MD, is employed by Cedars-Sinai Medical Center and by the Angeles Clinic and Research Institute.
All relevant financial relationships have been mitigated.
The person(s) above served as the developer(s) of this activity. Additionally, the Annual Meeting Steering Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.